Decitabine studies in chronic and acute myelogenous leukemia.
Kantarjian
H M
HM
MD Anderson Cancer Center, Department of Hematology, Houston, Texas 77030, USA.
O'Brien
S M
SM
Estey
E
E
Giralt
S
S
Beran
M
M
Rios
M B
MB
Keating
M
M
de Vos
D
D
Talpaz
M
M
D000328:Adult; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects / Q000627:therapeutic use*; D001374:Azacitidine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D001853:Bone Marrow / Q000473:pathology; D000077209:Decitabine; D005260:Female; D005334:Fever; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
D000964:Antimetabolites, Antineoplastic; D000077209:Decitabine; D001374:Azacitidine